Compare Abbott Laboratories (ABT) vs Cipher Mining Inc (CIFR) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Cipher Mining Inc — how do they compare? Abbott Laboratories trades at $95.61 (market cap $166.94B), while Cipher Mining Inc trades at $20.67 (market cap $8.41B). The key difference: Abbott Laboratories is far larger — about 19.9× Cipher Mining Inc's market cap, and Abbott Laboratories pays a 2.63% dividend while Cipher Mining Inc pays none. Which is the better fit depends on your goals.
| ABT | CIFR | |
|---|---|---|
Market Cap | $166.94B | $8.41B |
Sector | Health | Basic Materials |
52-Week High | $136.62 | $29.18 |
52-Week Low | $82.57 | $4.72 |
Enterprise Value | $193.69B | $12.45B |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
CIFR trades at $21.73, up 8.43% today but remains in a bearish technical trend. The company is transitioning from Bitcoin mining to AI data center operations, with $11.4B in contracted lease revenue from AWS and Fluidstack. Despite strong analyst support (13 buy ratings), fundamentals show deep losses with -427.79% net margin and negative cash flow from operations.
The investment case hinges on successful execution of the AI infrastructure pivot, with revenue expected to ramp from 2027. Key risks include high valuation multiples, negative profitability, and execution challenges in data center deployment. The consensus price target of $31.61 suggests 45% upside if the transition succeeds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Cipher Mining Inc
Cipher Mining is an industrial-scale technology company focused on Bitcoin mining infrastructure. It develops and operates data centers in the US designed to strengthen the Bitcoin network and support decentralized finance.
Read more on CIFR →
